| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |